The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer
Open accessAbstract
BACKGROUND: Preoperative radiotherapy (RT) decreases local recurrence rate and improves survival in stage II and III rectal cancer patients. The combination of chemotherapy with RT has a sound radiobiological rationale, and phase II trials of combined chemoradiation (CRT) have shown promising activity in rectal cancer. OBJECTIVES: To compare preoperative RT with preoperative CRT in patients with resectable stage II and III rectal cancer. SEARCH METHODS: We searched the Cochrane Register of Controlled Trials, Web of Science, Embase.com, and Pubmed from 1975 until June 2012. A manual search was performed of Ann Surg, Arch Surg, Cancer, J Clin Oncol, Int J Radiat Oncol Biol Phys and the proceedings of ASTRO, ECCO and ASCO from 1990 until June 2012. SELECTION CRITERIA: Relevant studies randomized resectable stage II or III rectal cancer patients to at least one arm of preoperative RT alone or at least one arm of preoperative CRT. DATA COLLECTION AND ANALYSIS: Primary outcome parameters included overall survival (OS) at 5 years and local recurrence (LR) rate at 5 years. Secondary outcome parameters included disease free survival (DFS) at 5 years, metastasis rate, pathological complete response rate, clinical response rate, sphincter preservation rate, acute toxicity, postoperative mortality and morbidity, and anastomotic leak rate. Outcome parameters were summarized using the Odds Ratio (OR) and associated 95% confidence interval (CI) using the fixed effects model. MAIN RESULTS: Five trials were identified and included in the meta-analysis. From one of the included trials only preliminary data are reported. The addition of chemotherapy to preoperative RT significantly increased grade III and IV acute toxicity (OR 1.68-10, P = 0.002) and marginally affected postoperative overall morbidity (OR 0.67-1.00, P = 0.05) while no differences were observed in postoperative mortality or anastomotic leak rate. Compared to preoperative RT alone, preoperative CRT significantly increased the rate of complete pathological response (OR 2.12-5.84, P < 0.00001) although this did not translate into a higher sphincter preservation rate (OR 0.92-1.30, P = 0.32). The incidence of local recurrence at five years was significantly lower in the CRT group compared to RT alone (OR 0.39-0.72, P < 0.001). No statistically significant differences were observed in DFS (OR 0.92-1.34, P = 0.27) or OS (OR 0.79-1.14, P = 0.58) at five years. AUTHORS' CONCLUSIONS: Compared to preoperative RT alone, preoperative CRT enhances pathological response and improves local control in resectable stage II and III rectal cancer, but does not benefit disease free or overall survival. The effects of preoperative CRT on functional outcome and quality of life are incompletely understood and should be addressed in future trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer
Sauer, R., Becker, H., Hohenberger, W., Rödel, C., Wittekind, C., Fietkau, R., Martus, P., Tschmelitsch, J., Hager, E., Hess, C. F., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040694 · Cited by 6,050
Parmar, M. K. B., Torri, V., & Stewart, L. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8 · Cited by 4,802
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
Kapiteijn, E., Marijnen, C. A. M., Nagtegaal, I. D., Putter, H., Steup, W. H., Wiggers, T., Rutten, H. J. T., Pahlman, L., Glimelius, B., van Krieken, J. H. J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010580 · Cited by 4,205
The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?
Heald, R. J., Husband, E. M., & Ryall, R. D. H. (1982) · Journal of British Surgery · doi:10.1002/bjs.1800691019 · Cited by 2,917
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
Bosset, J.-F., Collette, L., Calais, G., Mineur, L., Maingon, P., Radosevic-Jelic, L., Daban, A., Bardet, E., Beny, A., & Ollier, J.-C. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060829 · Cited by 2,688
LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTION
Quirke, P., Dixon, M. F., Durdey, P., & Williams, N. S. (1986) · The Lancet · doi:10.1016/s0140-6736(86)92612-7 · Cited by 1,973
Gérard, J.-P., Conroy, T., Bonnetain, F., Bouché, O., Chapet, O., Closon-Dejardin, M.-T., Untereiner, M., Leduc, B., Francois, É., Maurel, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.7629 · Cited by 1,731
Rectal Cancer: The Basingstoke Experience of Total Mesorectal Excision, 1978-1997
Heald, R. J., Moran, B. J., Ryall, R. D. H., Sexton, R., & MacFarlane, J. K. (1998) · Archives of Surgery · doi:10.1001/archsurg.133.8.894 · Cited by 1,399
Prospective comparison of faecal incontinence grading systems
Vaizey, C. J., Carapeti, E., Cahill, J. A., & Kamm, M. A. (1999) · Gut · doi:10.1136/gut.44.1.77 · Cited by 1,372
Bujko, K., Nowacki, M. P., Nasierowska-Guttmejer, A., Michalski, W., Bebenek, M., & Kryj, M. (2006) · British Journal of Surgery · doi:10.1002/bjs.5506 · Cited by 1,244
Peeters, K. C. M. J., Marijnen, C. A. M., Nagtegaal, I. D., Kranenbarg, E. K., Putter, H., Wiggers, T., Rutten, H., Pahlman, L., Glimelius, B., Leer, J. W., et al. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000257358.56863.ce · Cited by 1,191
Peeters, K. C. M. J., van de Velde, C. J. H., Leer, J. W. H., Martijn, H., Junggeburt, J. M. C., Kranenbarg, E. K., Steup, W. H., Wiggers, T., Rutten, H. J., & Marijnen, C. A. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.779 · Cited by 943
MERCURY Study Group (2006) · BMJ · doi:10.1136/bmj.38937.646400.55 · Cited by 923
(2001) · The Lancet · doi:10.1016/s0140-6736(01)06409-1 · Cited by 870
Nagtegaal, I. D., Marijnen, C. A. M., Kranenbarg, E. K., van de Velde, C. J. H., & van Krieken, J. H. J. M. (2002) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200203000-00009 · Cited by 746
Påhlman, L. (2001) · The Lancet · Cited by 529
Dahlberg, M., Glimelius, B., Graf, W., & Påhlman, L. (1998) · Diseases of the Colon & Rectum · doi:10.1007/bf02235256 · Cited by 456
Vecchio, F. M., Valentini, V., Minsky, B. D., Padula, G. D. A., Venkatraman, E. S., Balducci, M., Miccichè, F., Ricci, R., Morganti, A. G., Gambacorta, M. A., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.11.017 · Cited by 423
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer
Noël, G., & Mazeron, J. J. (2002) · Cancer/Radiothérapie · doi:10.1016/s1278-3218(02)00192-0 · Cited by 338
Enker, W. E., Merchant, N., Cohen, A. M., Lanouette, N. M., Swallow, C., Guillem, J., Paty, P., Minsky, B., Weyrauch, K., & Quan, S. H. Q. (1999) · Annals of Surgery · doi:10.1097/00000658-199910000-00010 · Cited by 299
Phase I/II Trial of Capecitabine, Oxaliplatin, and Radiation for Rectal Cancer
Rödel, C., Grabenbauer, G. G., Papadopoulos, T., Hohenberger, W., Schmoll, H.-J., & Sauer, R. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.505 · Cited by 275
Holm, T., Singnomklao, T., Rutqvist, L.-E., & Cedermark, B. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960901)78:5<968::aid-cncr5>3.0.co;2-8 · Cited by 274
Wassif, S. B., Gérard, A., Loygue, J., Camelot, D., Buyse, M. E., & Duez, N. J. (1984) · Cancer · Cited by 224
Minsky, B. D., Cohen, A. M., Enker, W. E., Saltz, L., Guillem, J. G., Paty, P. B., Kelsen, D. P., Kemeny, N., Ilson, D., Bass, J., et al. (1997) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00487-7 · Cited by 184
Bosset, J. F., Calais, G., Daban, A., Berger, C., Radosevic-Jelic, L., Maingon, P., Bardet, E., Pierart, M., & Briffaux, A. (2004) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.032 · Cited by 176
van den Brink, M., Stiggelbout, A. M., van den Hout, W. B., Kievit, J., Klein Kranenbarg, E., Marijnen, C. A. M., Nagtegaal, I. D., Rutten, H. J. T., Wiggers, T., & van de Velde, C. J. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.023 · Cited by 167
Training and quality assurance for rectal cancer: 20 years of data is enough
Quirke, P. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01248-8 · Cited by 155
Preoperative radiochemotherapy in rectal cancer:
Bosset, J.-F., Magnin, V., Maingon, P., Mantion, G., Pélissier, É., Mercier, M., Chaillard, G., & Horiot, J.-C. (2000) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(99)00411-3 · Cited by 151
Latkauskas, T., Paužas, H., Gineikienė, I., Jančiauskienė, R., Juozaitytė, E., Saladžinskas, Ž., Tamelis, A., & Pavalkis, D. (2011) · Colorectal Disease · doi:10.1111/j.1463-1318.2011.02815.x · Cited by 108
The Radiobiology of Conventional Radiotherapy and Its Application to Radionuclide Therapy
Dale, R., & Cárabe, A. (2005) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2005.20.47 · Cited by 107
Ammann, K. (2003) · Archives of Surgery · doi:10.1001/archsurg.138.3.257 · Cited by 92
Siegel, R., Burock, S., Wernecke, K., Kretzschmar, A., Dietel, M., Loy, V., Koswig, S., Budach, V., & Schlag, P. M. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-50 · Cited by 87
Bujko, K., Nowacki, M. P., Kępka, L., Olędzki, J., Bębenek, M., Kryj, M., & the Polish Colorectal Study Group (2005) · Colorectal Disease · doi:10.1111/j.1463-1318.2005.00796.x · Cited by 82
Bosset, J.-F., Calais, G., Mineur, L., Maingon, P., Radošević-Jelić, L., Daban, A., Bardet, É., Beny, A., Ollier, J., & Collette, L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.23.16_suppl.3505 · Cited by 70
Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy
Feliú, J., Calvillo, J., Escribano, A., de Castro, J., Sanchez, M. E., Mata, A. G., Espinosa, E., Grande, A. G., Mateo, A., & Barón, M. G. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf116 · Cited by 65
Beets‐Tan, R. G. H., & Beets, G. L. (2003) · International Journal of Colorectal Disease · doi:10.1007/s00384-003-0480-5 · Cited by 58
Pre-operative imaging of rectal cancer and its impact on surgical performance and treatment outcome
Beets‐Tan, R. G. H., Lettinga, T., & Beets, G. L. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.02.015 · Cited by 37
Glimelius, B. L. G. (2002) · British Medical Bulletin · doi:10.1093/bmb/64.1.141 · Cited by 35
Neoadjuvant Chemoradiation for Locally Advanced Carcinoma of the Rectum
Osti, M. F., Valeriani, M., Masoni, L., Tombolini, V., & Enrici, R. M. (2004) · Tumori Journal · doi:10.1177/030089160409000308 · Cited by 19
Cited by
Kuipers, E. J., Grady, W. M., Lieberman, D., Seufferlein, T., Sung, J. J., Boelens, P. G., van de Velde, C. J. H., & Watanabe, T. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.65 · Cited by 1,563
Schmoll, H. J., Van Cutsem, E., Stein, A., Valentini, V., Glimelius, B., Haustermans, K., Nordlinger, B., van de Velde, C. J., Balmana, J., Regula, J., et al. (2012) · Annals of Oncology · doi:10.1093/annonc/mds236 · Cited by 1,510
Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Cederquist, L., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Engstrom, P. F., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0061 · Cited by 944
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology
Benson, A. B., Venook, A. P., Al-Hawary, M. M., Azad, N., Chen, Y.-J., Ciombor, K. K., Cohen, S., Cooper, H. S., Deming, D., Garrido-Laguna, I., et al. (2022) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2022.0051 · Cited by 827
Practice Parameters for the Management of Rectal Cancer (Revised)
Monson, J. R. T., Weiser, M. R., Buie, W. D., Chang, G. J., Rafferty, J. F., Buie, W. D., Rafferty, J., Guillem, J., Boushey, R., Chang, G., et al. (2013) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0b013e31828cb66c · Cited by 563
Metadata
- Authors
- De Caluwé, L., Van Nieuwenhove, Y., & Ceelen, W. P.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2013-02-28
- Volume
- 2013
- Issue
- 2
- Pages
- CD006041-CD006041
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1739333826
- Cited by
- 292
- References
- 40
- FWCI
- 15.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.